Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Apple and Broadcom extended their chip partnership through 2031 as AI hardware demand raises pressure on suppliers, pricing, and device costs. If you can only read one tech story a day, this is it. We ...